21 CFR Part 211 details the current good manufacture practice for finished pharmaceuticals. It covers requirements ... the component as labeled prior to release for use in drug product manufacturing.

These companies now have until December 31, 2025, to upgrade their facilities and meet the enhanced standards. The extension ...

To support compliance, the government revised Schedule M of the Drugs and Cosmetics Rules, 1945, in 2023, outlining phased ...

Gland Pharma Ltd. received the establishment inspection report from US FDA, confirming that the good manufacturing practices ...

Telangana: Gland Pharma has received Establishment Inspection Report (EIR) from the United States Food and Drug ...

The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

India extended the deadline for small- and medium-sized pharmaceutical companies to comply with revised GMP compliance under ...

Small and medium-sized pharmaceutical companies are preparing to comply with the provisions of the revised Schedule M, which ...

These companies now have until December 31, 2025, to comply with the improved manufacturing practices. The extension comes following requests from manufacturing units to upgrade their facilities, the ...

Gland Pharma Ltd shares gained almost 3% on Thursday after the company announced receiving a Good Manufacturing Practice (GMP ...

Indore: With the mandatory enforcement of the revised Schedule M manufacturing standards implemented from January 1, 2025, the Food and Drug Administr.

Hyderabad: Gland Pharma has announced that the Company has received Establishment Inspection Report (EIR) from the US Food ...